Clinical trials sponsored by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
8
Recruiting trials
11
Conditions studied
Phase breakdown
Phase 1 1Phase 2 6Phase 3 1
Conditions studied
Recruiting trials led by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities
- A Phase II Study of SKB571 in Patients With Lung Cancer
- A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
- A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy
- A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants
- SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.
- SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer
- SKB500 Combinations in Patients With Small Cell Lung Cancer
Common questions
How many trials is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. recruiting for?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is the lead sponsor of 8 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.